- Home
- RAPT vs IQ Comparison
RAPT vs IQ Comparison
Compare RAPT & IQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RAPT | IQ |
|---|---|---|
| Founded | 2015 | 2009 |
| Country | United States | China |
| Employees | 60 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RAPT | IQ |
|---|---|---|
| Price | $58.00 | $1.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $56.22 | $2.91 |
| AVG Volume (30 Days) | 4.1M | ★ 8.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.71 | $1.50 |
| 52 Week High | $57.99 | $2.76 |
Technical Indicators
Market Signals| Indicator | RAPT | IQ |
|---|---|---|
| Relative Strength Index (RSI) | 78.59 | 25.79 |
| Support Level | $32.00 | N/A |
| Resistance Level | N/A | $2.16 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | -0.79 | -0.03 |
| Stochastic Oscillator | 95.31 | 17.92 |
Price Performance
Historical ComparisonAbout RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About IQ iQIYI Inc.
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.